Favipiravir

«Favipiravir, also known as T-705, Avigan, or favilavir is an antiviral drug being developed by Toyama Chemical (Fujifilm group) of Japan with activity against many RNA virus. Like certain other experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. In experiments conducted in animals Favipiravir has shown activity against influenza virus, West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses.[1] Activity against enteroviruses[2] and Rift Valley fever virus has also been demonstrated.[3] Favipiravir has showed limited efficacy against Zika virus in animal studies, but was less effective than other antivirals such as MK-608.[4] The agent has also shown some efficacy against rabies,[5] and has been used experimentally in some humans infected with the virus.[6]

  • Has Subnodes:

Pathways of Favipiravir

Textual paths of Biolinks with Validity Score > 3.0
Calculate
Uses in-app credits Help
This tool shows paths like: A B C Favipiravir

Mindmaps

Visualisation of logical biolinks between drugs, supplements, symptoms etc..
Generic SubmitterPRO ranked added it 2 years ago on Mar 27, 2020